IOVA

Iovance Biotherapeutics Inc. Common Stock (IOVA)

Stock · NASDAQ · Health Care

$8.01as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Support level
$3.81
Industry
Biotechnology: Biological Products (No Diagnostic Substances)

Iovance Biotherapeutics Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • IOVA
    Iovance Biotherapeutics Inc. Common Stock
    $8.01
    ▼ 3.03%
    Market cap $2.77BP/E
  • TARS
    Tarsus Pharmaceuticals Inc. Common Stock
    $71.84
    ▼ 0.12%
    Market cap $2.81BP/E
    $48.2$85.25
  • BEAM
    Beam Therapeutics Inc. Common Stock
    $29.31
    ▼ 3.84%
    Market cap $2.81BP/E
    $16.02$38.26
  • KOD
    Kodiak Sciences Inc Common Stock
    $37.77
    ▼ 3.45%
    Market cap $2.84BP/E
    $8.29$47.84
  • COAG
    Hemab Therapeutics Holdings Inc. Common Stock
    $44.77
    ▼ 9.55%
    Market cap $2.44BP/E
    $23$55.42
  • MESO
    Mesoblast Limited American Depositary Shares
    $17.42
    ▼ 4.18%
    Market cap $2.02BP/E
    $1.88$3.31
  • RLAY
    Relay Therapeutics Inc. Common Stock
    $18.78
    ▼ 3.30%
    Market cap $3.78BP/E
    $3.5$21.27

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
258.73M
Total value held
$874.49M
Institutional holders
280
Top holders this quarter
  • Unknown31.08M
  • Unknown28.97M
  • Unknown17.45M
  • Unknown16.62M
  • Unknown13.69M
  • Unknown9.41M
  • Unknown8.76M
  • Unknown8.57M
  • Unknown8.50M
  • Unknown8.49M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.